Practical execution of defect preparation prior to surgical cartilage intervention: results from a representative meeting survey among experts by unknown
Salzmann et al. SpringerPlus  (2015) 4:682 
DOI 10.1186/s40064-015-1451-3
MEETING REPORT
Practical execution of defect preparation 
prior to surgical cartilage intervention: 
results from a representative meeting survey 
among experts
Gian M. Salzmann1, Philipp Niemeyer2, Stephan Vogt4, Peter Kreuz5, Markus Arnold6, Jürgen Fritz7, 
Ayeesha Mujeeb8, Ralf Rosenberger9, Matthias Steinwachs10 and Peter Angele3*
Abstract 
During a specialised orthopedic meeting held on ‘the state of the art in cartilage defect repair’, all previously fully-
registered participants were requested to participate in an electronic survey by the use of a moderator-presented 
“Power Point Presentation-based” 9-item questionnaire. The aim of this survey was to assess indication, approach, and 
treatment execution of cartilage defect debridement prior to planned microfracture (MFX) or autologous chondro-
cyte implantation (ACI). All participants completed the questionnaire (n = 146) resulting in a return rate of 100 %. An 
uncertainty exists as to whether the removal of the calcifying layer prior to cartilage repair must be carried out or not. 
The same was true for the acceptability of subchondral bleeding prior to microfracturing and its handling prior to 
autologous chondrocyte implantation. There is a degree of unanimity among experts regarding the management of 
osteophytes and bone marrow edema. In a homogenous society collective of consultants that frequently deal with 
cartilage defective pathologies, there still remain a significant heterogeneity in selected topics of defect debridement.
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Background
Cartilage defects are being recognised with increasing 
frequency (Widuchowski et  al. 2007). Apart from the 
rapid ageing of the population, today’s society is progres-
sively demanding and indulging in more and extreme 
sporting activity (Filardo et al. 2014). Therefore, cartilage 
defect treatment is being performed with the same cumu-
lating trend. The spectrum of tools and techniques avail-
able on offer for the surgeon has significantly broadened 
over time (Gobbi et al. 2014; Crawford et al. 2012; Cuc-
chiarini et  al. 2014; De Bari and Dell’accio 2008; Khaz-
zam 2013; Abrams et al. 2013; Bhardwaj et al. 2014; Liu 
et al. 2013). The current evidence is still conflicting when 
cartilage repair techniques are concerned. However, 
guidelines are now available as a point of reference (Nie-
meyer et  al. 2013). Yet, such are naturally developed by 
a local group of specialists and thus have not necessar-
ily to be accepted on an international level. Furthermore, 
these do include the traditional techniques of microf-
racture, chondrocyte transplantation and osteochondral 
transplantation; not considering more novel techniques 
available in the market. Opposing the emergence of nov-
elty, one is in danger to neglect basic techniques (Gomoll 
and Minas 2014; Hindle et  al. 2014; Pietschmann et  al. 
2014) of cartilage repair which include patient selection, 
addressing co-pathologies, rehabilitation and foremost 
elementary surgical techniques. Such basics have to be 
considered equally important in order to realise optimal 
treatment outcome for the benefit of the patient. Addi-
tionally, quality evidence is required to accompany oper-
ative conversion in the operating room. Prior to most 
cartilage repair techniques the defect has to be prepared 
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for an optimal consecutive regeneration, independent of 
technical intention (Gomoll et  al. 2011, 2012a, 2012b; 
Gomoll and Minas 2014; Henn and Gomoll 2011). The 
majority of these contain statements such as ‘removal of 
defective cartilage and calcifying layer down to the sub-
chondral bone’, ‘preparing stable surrounding cartilage’, 
‘avoid bleeding’ or ‘removal of osteophytes’. Interpreta-
tion and potential execution of these descriptions does 
not have to be consequently uniform. To the best of our 
knowledge, it has not been analysed before. The aim of 
this particular presented study was to analyse the exact 
debridement technique prior to planned MFX or ACI, 
which are the two most prevalent techniques used clini-
cally at this time.
Methods
At the end of a committee session during the course of 
a musculoskeletal meeting (Society for Arthroscopy 
and Joint Surgery  =  Gesellschaft für Arthroskopie und 
Gelenkchirurgie; AGA 2013, Wiesbaden, Germany) on 
the state of the art in cartilage defect repair all previously 
fully-registered participants were spontaneously involved 
in an electronic survey by the use of a ‘Power Point Pres-
entation-based’ 9-item questionnaire. Participants had to 
electronically identify upon submission, but were further 
blinded for handling the outcome analysis. The ques-
tions were previously designed by all members of the 
AGA cartilage committee in consensus and presented by 
an independent moderator to the participants. The par-
ticipants were capable of answering the posed questions 
independently from their respective seats by the use of 
an electronic device. The questions were multiple-choice 
with only one possible answer to choose. Participants 
were advised not to discuss their choice of answer dur-
ing the survey with surrounding neighbours. The inform-
ants were asked to reference their opinion on treatment 
of cartilage defects exclusively at the knee joint (with the 
exception of item 1, see Table 1). This survey was com-
menced to explore indication and treatment modalities 
when cartilage defect preparation is concerned among 
a homogenous population of highly active experienced 
and accredited musculoskeletal surgeons from the Ger-
man-speaking society of Arthroscopy (AGA, http://www.
aga-online.de). The AGA is a scientific association of 
physicians and scientists interested in arthroscopy and 
associated issues (e.g. cartilage repair). The AGA now 
has more than 3900 members and is thus Europe’s largest 
professional society for Arthroscopy in display of a rep-
resentative population. The spontaneous survey included 
all participants of the session (n = 146). It was a 9-item 
Power Point-based electronic questionnaire with one 
question per page (power point slide) (Table  1). Results 
were directly presented and discussed with all workshop 
participants after completion of the survey. Data output/
analysis was done descriptively without further statistical 
analysis.
Table 1 Overview of the nine questions that were posed to the audience
MFX microfracture, ACI autologous chondrocyte implantation
Frequency of cartilage 
surgery per year
None 10 10–50 51–100 >100
Preparation prior to MFX Never To calcifying layer Partially remove calcifying 
layer
Complete removal of 
calcifying layer
Into subchondral bone
Preparation prior to ACI Never To calcifying layer Partially remove calcifying 
layer




dral bleeding prior to 
MFX
No Spot bleeding Spread bleeding n/a n/a
Acceptance of subchon-
dral bleeding prior 
to ACI
No Spot bleeding Spread bleeding n/a n/a
Management of bleed-
ing prior to ACI




Topic unknown Ignore Removal with curette Removal with burr Other technique
How deep to remove 
intralesional osteo-
phytes
Not Partially over base of 
subchondral bone
Complete removal a 
niveau of subchondral 
bone
Complete removal under 




BME affect cartilage 
defect treatment
Yes No n/a n/a n/a
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Results
All session participants completed the questionnaire 
(n = 146) resulting in a return rate of 100 %. There were 
n = 130 consultants and n = 16 residents. A total of 121 
were from Germany, 10 from Austria, 8 from Switzer-
land, 3 from Czeck Republic, 2 from Italy, and 1 each 
from Poland/Slovakia. From the participants, 12.8  % 
stated to never carry out cartilage repair, 12.8 % chose to 
conduct less than 10 interventions/year, 38.5 % between 
10 and 50 interventions/year, 25.6  % between 51 and 
100 interventions/year, and 10.3  % over 100 inteven-
tions/year, respectively. The answers to the questions 
listed in the questionnaire (Table  1, methods section) 
were collected in a chronological order and the data was 
recorded as follows (Table  2). Defect preparation prior 
to planned microfracture; never (2.7  %), to calcifying 
layer (27.0 %), partially removing calcifying layer (8.1 %), 
complete removal (59.5  %), and into subchondral bone 
(2.7 %). Defect preparation prior to planned ACI; never 
(0.0  %), to calcifying layer (23.1  %), partially removing 
calcifying layer (5.1 %), complete removal (61.5 %), and 
into subchondral bone (10.3 %). Acceptance of subchon-
dral bleeding during preparation prior to planned micro-
fracture; no (5.6  %), spot (88.9  %), and spread (5.6  %). 
Acceptance of subchondral bleeding during prepara-
tion prior to planned ACI; no (40 %), spot (57.5 %), and 
spread (2.5  %). Management of subchondral bleeding 
prior to ACI; no therapy (30.2 %), manual compression 
(20.9  %), electrocauthery (7.0  %), fibrin glue (20.9  %), 
and adrenalin (20.9 %). Handling of intralesional osteo-
phytes; not known (0.0 %), ignore (0.0 %), removal with 
curette (73.8  %), removal with burr (23.8  %), and other 
technique of removal (2.4  %). The removal of intrale-
sional osteophytes according to depth; not (2.0 %), par-
tially over base of subchondral bone (0.0  %), complete 
removal a niveau (84.3 %), and complete removal below 
niveau (13.7  %). The final question, indicating whether 
bone marrow edema influences cartilage defect treat-
ment 85.7  % respondents selected ‘yes’, whereas 14.3  % 
answered ‘no’.
Discussion
The most important finding of this survey was that until 
today defect preparation prior to planned cartilage defect 
surgery is not totally uniform among a collective highly 
specialised joint surgeons (n = 130 consultants). Appar-
ently, it is not totally clear and there is no consensus on 
how to remove or treat the calcifying layer before MFX 
or ACI, with approximately 40  % of the participants 
selecting the wrong answer (the answer which was not 
defined as correct by the committee members). A simi-
lar answering behaviour was true in terms of acceptabil-
ity of subchondral bleeding prior to microfracturing and 
its handling prior to autologous chondrocyte implanta-
tion. Yet, there was consistent agreement on the surgical 
handling of osteophytes and the management of existing 
bone marrow edema in terms of giving the anticipated 
reply.
Table 2 Same table as Table 1 with overview of the nine questions that were posed to the audience
The percental answering behaviour of all 146 survey participants is now added to every possible answering possibility
Italics indicate answering percentage
Frequency of cartilage 
surgery per year
None 12.8 % 10 12.8 % 10–50 38.5 % 51–100 25.6 % >100 10.3 %
Preparation prior to MFX Never 2.7 % To calcifying layer 27.0 % Partially remove calcify-
ing layer 8.1 %
Complete removal of 
calcifying layer 59.5 %
Into subchondral bone 
2.7 %
Preparation prior to ACI Never 0.0 % To calcifying layer 23.1 % Partially remove calcify-
ing layer 5.1 %
Complete removal of 
calcifying layer 61.5 %
Into subchondral bone 
10.3 %
Acceptance of subchon-
dral bleeding prior to 
MFX
No 5.6 % Spot bleeding 88.9 % Spread bleeding 5.6 % n/a n/a
Acceptance of subchon-
dral bleeding prior 
to ACI
No 40.0 % Spot bleeding 57.5 % Spread bleeding 2.5 % n/a n/a
Management of bleeding 
prior to ACI
No 30.2 % Manual compression 20.9 Electrocauthery 7.0 % Fibrin glue 20.9 % Adrenalin 20.9 %
Treatment of intralesional 
osteophytes prior to ACI
Unknown 0.0 % Ignore 0.0 % Removal with curette 
73.8 %
Removal with burr 23.8 % Other 2.4 %
How deep to remove 
intralesional osteo-
phytes
Not 2.0 % Partially over base of sub-
chondral bone 0.0 %
Complete removal a 
niveau of subchondral 
bone 84.3 %
Complete removal under 




BME affect cartilage 
defect treatment
Yes 85.7 % No 14.3 % n/a n/a n/a
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In general, such survey data are truly not representative 
for worldwide surgical execution, however here we have 
provided circumstances that propose a highly selected 
collection of consultants with the desire to offer standard 
care. More than 35  % of the participants stated to per-
form cartilage surgery between 51 and100 times/year 
(without single debridement) and another approximately 
40 % between 10 and 50 times/year. Such numbers give 
insight to the fact that such operations are rather fre-
quent and may propose one quarter of all interventions 
in selected institutions. Furthermore, concomitant car-
tilage surgery has to be clearly estimated equally impor-
tant since anterior cruciate (Unay et al. 2014) or medial 
patellofemoral (Siebold et  al. 2014) ligament ruptures 
are frequently associated with cartilage defects at typi-
cal locations. The surgeon in charge should be expected 
to be in the position to treat and primarily debride these 
lesions according to current evidence. If such is lacking, 
decision making can be dependent on a variety of rea-
sons. Concurrently, one’s surgical approach would be 
performed i.e. in the way it has been taught. By ways of 
optimal cartilage defect care chances for the patient are 
believed to rise to prevent unwanted joint degeneration.
Defect preparation is the initial and equally important 
step prior to repairing techniques. Frisbie and colleagues 
have studied the microfracture technique within large, 
full-thickness medial femoral condyle articular cartilage 
defects in an equine model in order to mimic lesions 
often observed in human patients. The horse may come 
closest to the clinical situation among currently available 
and accepted animal models, and thus has to be regarded 
representative (Chu et  al. 2010). However, one has to 
notice that there is always a certain disparity between 
animal models and a clinical situation. The group (Fris-
bie et  al. 2006) divided horses (n =  12) into two differ-
ent groups. The first group was microfracture without 
prior removal of the calcified layer. The second group 
was with prior removal below the tidemark. The final 
repair tissue was assessed by the use of arthroscopy, clini-
cal examination, radiographic, and magnetic resonance 
imaging examinations, biopsy (at 4  months), gross and 
histopathologic examinations (at 12 months), and finally 
mRNA as well as immunohistochemical evaluations. 
When the calcified cartilage layer was removed and the 
subchondral bone plate was left intact the authors identi-
fied an increased overall repair tissue during arthroscopic 
(4 months) and gross evaluation (12 months). Yet, when 
the calcified layer was removed an increase in the level 
of the subchondral bone was still observed. The authors 
concluded that a removal of the calcified cartilage layer 
may provide an optimal amount and attachment of the 
resulting repair tissue. Previous experimental data under-
line this information where less repair tissue attachment 
had been seen in a study in which small areas of calci-
fied cartilage were presumably not debrided at the time 
of defect creation. Also in that same previous study, an 
increase in tissue filling but no difference in tissue mor-
phology was observed when comparing lesions that 
were or were not microfractured to the level of the sub-
chondral bone plate (Frisbie et al. 2003). Independently, 
authors have reported on frequent intralesional osteo-
phyte formation in the aftermath of microfracture appli-
cation under clinical circumstances (Pestka et  al. 2012; 
Minas et al. 2009), which may be connected to remodel-
ling processes at the subchondral bone. While this state-
ment is not clearly underlined by current literature, it is 
equally important to retain the subchondral bone after 
removal of the calcified layer, which has been provided by 
another study conducted on horses (Hendrix et al. 2010). 
A recent survey among Canadian orthopedic surgeons 
revealed comparable, to our survey, interesting informa-
tion since only 69 % of respondents removed the calcified 
cartilage layer prior to creating the perforations when 
performing microfracture surgery (Theodoropoulos et al. 
2012). A current study by Mika and co-workers revealed 
in a controlled laboratory study involving sheep and 
humans that traditional debridement techniques for ACI 
using a ring curette do not violate the normal subchon-
dral bone plate in vitro or in vivo.
It has been well established and verified by multiple 
in vitro and in vivo studies (Forsyth et al. 2012) that joint 
hematoma following e.g. trauma or among hemophilic 
subjects has clear detrimental effects, in particular with 
the articulating cartilage (Sward et  al. 2014). With the 
idea of ACI and its associated technical aspects such as 
bleeding Sosio and co-workers expanded swine articu-
lar chondrocytes and seeded those onto collagen mem-
branes. The membranes were cultured for 3 days in the 
presence of different concentrations of peripheral blood. 
All seeded samples showed an increase in weight. Fur-
thermore the authors noted an evident cartilage-like 
matrix production. A concentration-dependent decrease 
in the mitochondrial activity related to blood contact 
was shown at earlier time points of culture. The authors 
concluded that blood contact of 3 days affected the chon-
drocytes’ activity. It induced a delay in the maturation of 
the engineered cartilage constructs (Sosio et al. 2011). In 
parallel, the topic of intralesional or subchondral bleed-
ing during cartilage defect repair can be found in almost 
every technical description. The theory behind this is 
that unwanted blood may interfere with the development 
of high quality cartilage, which by anatomic definition is 
without vessels. Since blood within the defect is wanted 
following MFX and the fraction of stem cells has been 
reported to be very low one may speculate that elevation 
of the subchondral plate and intralesional osteophytes 
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may be related to such hematoma. Interestingly, the liter-
ary evidence on that topic is very scarce. There is actually 
no article comparing intra-defect bleeding and consecu-
tive ACI versus no bleeding and consecutive ACI. There 
is one report comparing in a small animal model two 
different surgical techniques during articular cartilage 
defect repair. The purpose of the study was to observe the 
difference in healing of full-thickness articular cartilage 
defects treated with burr arthroplasty versus subchon-
dral drilling. Cartilage was shaved off the medial femoral 
condyles of 39 rabbits without penetrating the subchon-
dral plate. In left knees, two 2.0-mm holes were drilled 
into the femoral condyle until bleeding was generated. 
The right knees underwent burr arthroplasty until the 
authors identified punctate bleeding. The animals were 
sacrificed at 6, 12, and 24  weeks postoperatively. Joint 
resurfacing and degenerative alterations were evaluated 
macroscopically and histologically. Degenerative changes 
in the cartilage surface were observed within both treat-
ment groups. Rabbits that underwent subchondral drill-
ing had increased fibrocartilaginous healing with a slight 
increase in degenerative changes across the joint. Burr 
arthroplasty subjects showed a significant decrease in 
cartilaginous coverage of the exposed joint surface as well 
as a progressive increase in direct degenerative changes. 
Although both techniques have to be declared subopti-
mal, histological evidence at 6 months does propose that 
subchondral drilling may result in a better repair than 
abrasion arthroplasty during the treatment of full-thick-
ness lesions (Menche et al. 1996).
The published nebulosity continues when treatment 
of intralesional osteophytes is illuminated. Periarticu-
lar osteophytes are very well-studied and clearly linked 
to aging, trauma, mechanical stress, and disease (van 
der Kraan and van den Berg 2007). Interestingly, eleva-
tion of the subchondral bone plate, intra-lesional bony 
overgrowth (BO) or intralesional osteophytes associ-
ated with cartilage repair have never been systemati-
cally studied. The true etiology remains unknown. Bony 
overgrowth rates of incidence linked to cartilage repair 
have been presented with a large range in variation from 
25–70 % for bone marrow stimulation, and from 23–64 % 
after ACI not necessarily being linked only to violation 
of the subchondral bone plate. A recent article by Shive 
reported on much less frequency of BO following MFX 
surgery and stated that such conditions may not essen-
tially be related to penetration of the underlying bone, 
but to other factors such as debridement, bleeding, and 
conditions that existed before the procedure. No rela-
tionship to the final clinical outcome was present at 
12 months in that study (Shive et al. 2014).
Over 80  % of respondents declared that cartilage-
defect associated BME does affect cartilage repair. Until 
today it is still not clear what a BME does represent 
(Roemer et  al. 2009, 2014; Zanetti et  al. 2000) and the 
evidence for the impact on outcome is conflicting. While 
Niemeyer (Niemeyer et  al. 2010) stated initially that 
BME at time of ACI is connected to a decreased clinical 
outcome, the opposite has just lately been reported by 
Ebert (Ebert et  al. 2014). Furthermore, Nemec (Nemec 
et  al. 2009) and Salzmann (Salzmann et  al. 2014) have 
reported that a regional BME is very frequent following 
cartilage repair (OCT and ACI, respectively), but not 
connected to clinical or MRI outcome.
In conclusion, we found that there exists a heterogene-
ous opinion when defect debridement prior to cartilage 
repair is concerned. The current evidence is in display of 
a comparable heterogeneity. More research and conse-
quent guidelines are needed in order to harmonise surgi-
cal steps during cartilage repair in the future.
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